There has also been increasing demand for its weight loss counterpart, Wegovy so much that Novo Nordisk announced earlier this month it will be limiting the availability of some starter doses
Popular GLP-1 drugs approved for weight loss cost more than they are worth, said David Kim, PhD, a health economist at University of Chicago
II), or the consolidation of these NAION cases into the existing MDL No
None of this means the drug is unsafe at scale, the STEP and SUSTAIN trials placed the discontinuation-for-AE rate at 4.3 percent, but the individual stories above are the people who landed inside that 4.3 percent
GLP-1s help to reduce the impacts of chronic stress and help to alter food reward pathways in positive ways and may help reduce alcohol and other substance use disorders (Mozafarriun et al 2025)
Every individuals physiology, medical history, existing conditions, and other medications create a unique context that only a healthcare professional can adequately assess